Immune to Cancer: The CRI Blog
-
New Clinical Trials to Offer Immunotherapy as Frontline Treatment for Lung Cancer
Patients with lung cancer will soon be able to receive immunotherapy as first-line treatment on an experimental…
-
When Is a Spot Not a Spot?
A ten-year effort to optimize a ubiquitous laboratory assay finally pays off.
-
Giving 100% to ‘100 in 100’ – YOU DID IT!
A big thank you to all of our supporters who made $100K in 100 Days a success!
-
Immunotherapy: 5 Ways to Stop Cancer
The Cancer Research Institute has created a series of short, animated videos that explain the basics of…
-
White Out Cancer 2015
More than 1,000 posts from around the globe were shared in the third annual event.
-
CRI Member to Chair Immuno-Oncology 360 Conference
Dr. Axel Hoos, a member of the CRI Scientific Advisory Council, will chair and be the keynote…
-
What Cancer Patients Should Know: Latest Immunotherapy News from ASCO
Learn the latest news in cancer immunotherapy for melanoma, lung cancer, leukemia, liver cancer, and other cancer…
-
ASCO 2015: Report from Day 5
The last day of the ASCO meeting featured talks on immunotherapy for pancreatic cancer, one the deadliest…
-
ASCO 2015: Report from Day 4
More cancers prove treatable with checkpoint blockade therapy. Today: kidney, bladder, and ovarian cancer.
Join CRI in Shaping the Future of Immunotherapy
Support the pioneering work of CRI in advancing immunotherapy.